$0.45-0.02 (-4.07%)
HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States.
HCW Biologics Inc. in the Healthcare sector is trading at $0.45. The stock is currently near its 52-week low of $0.25, remaining 80.9% below its 200-day moving average. Technical signals show neutral RSI of 62 and bullish MACD crossover, explaining why HCWB maintains its current current market pressure. The Whystock Score of 30/100 signals elevated caution as indicators diverge.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States. The company's lead products include HCW921...
YY Group Holdings Ltd. 26,117,734 0.0511
US stocks look set to open little changed in Friday's trading session ahead of consumer sentiment da
US stock futures were little changed in Friday's premarket session ahead of consumer sentiment and o
NasdaqCM:HCWB 1 Year Share Price vs Fair Value Explore HCW Biologics's Fair Values from the Community and select yours...
The recent 14% drop in HCW Biologics Inc.'s ( NASDAQ:HCWB ) stock could come as a blow to insiders who purchased...